Metropolis Healthcare Limited (METROPOLIS) — Announcement | 10 August 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Q1 FY27 revenue grew 17% YoY to INR 450 crores with EBITDA margin at 25.2%
🔄 What Changed
EBITDA margin expanded 210 bps YoY to 25.2%
🔮 What's Next
FY27 revenue growth guidance of 14%-15% and EBITDA margin target of 27%-28%
💡 Investor Takeaway
Shareholders should note the company is executing on volume-driven growth and margin expansion while targeting 45% Specialty Diagnostics contribution by FY27 through network expansion and digital transformation.

Metropolis Healthcare reported 17% YoY revenue growth to INR 450 crores in Q1 FY27, driven by 10% patient volume growth and strong B2B/B2C expansion, with EBITDA margin rising 210 bps to 25.2%. Management reaffirmed FY27 revenue growth guidance of 14%-15% and EBITDA margin target of 27%-28%, citing structural industry tailwinds, expansion into Tier-2/3 markets with 400-500 new centers planned, and integration progress of Core Diagnostics boosting genomics capabilities and North India share to 18%.

📄 View Original Announcement (PDF)

About Metropolis Healthcare Limited (METROPOLIS)

Healthcare · Healthcare · Listed on NSE

Market Cap: ₹12,082.27 Cr P/E: 25.0 ROE: 13.5% ROCE: 19.8% Div Yield: 0.86%

View full METROPOLIS stock details →

📡 Get AI alerts when METROPOLIS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track METROPOLIS — Free

📊 More METROPOLIS filings

See all METROPOLIS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when METROPOLIS files new disclosures

Track METROPOLIS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track METROPOLIS — Free

Free account · 2 AI queries/day